SC
AIMT

Sculptor Capital’s Aimmune Therapeutics AIMT Stock Holding History

Sculptor Capital’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-176,300
Closed -$6.07M – 586
2020
Q3 		$6.07M Buy
+176,300
New +$3.75M 0.04% 158

Sculptor Capital's AIMT Position: Q4 2020 in Review

Sculptor Capital sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 144,900 shares — an estimated $4.99M sold.

Sculptor Capital first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $4.99M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Sculptor Capital reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Sculptor Capital sold 144,900 Aimmune Therapeutics shares in Q4 2020, an estimated $4.99M.
  • Sculptor Capital first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
  • Sculptor Capital's Aimmune Therapeutics position peaked at $4.99M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Sculptor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.